Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reporting a beneficial ownership of 6.4% of HubSpot Inc.'s common stock as of March 31, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, confirming its passive beneficial ownership of 7.8% of International Paper Company's common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, revealing its continued passive beneficial ownership of 7.9% of KeyCorp's common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.2% beneficial ownership stake in Artesian Resources Corp's Class A Stock as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 18 to its Schedule 13G, disclosing a 9.0% beneficial ownership stake in Ashland Inc.'s common stock as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, disclosing a continued beneficial ownership of 9.5% of Avnet Inc.'s common stock as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 15 to its Schedule 13G, reporting a 7.9% beneficial ownership of common stock in Bank of Marin Bancorp as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.5% passive beneficial ownership stake in Blue Bird Corporation as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.1% beneficial ownership stake in Bristol Myers Squibb Co. as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 6.8% passive beneficial ownership stake in Caribou Biosciences, Inc. as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.2% beneficial ownership stake in Century Aluminum Co. as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 14.2% beneficial ownership stake in Chemours Company as of March 31, 2025, held for passive investment purposes.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reaffirming its beneficial ownership of 7.6% of EXPAND ENERGY CORP's common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 9.1% beneficial ownership stake in semiconductor company Cirrus Logic Inc. as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 10 to its Schedule 13G, reporting a 6.9% beneficial ownership stake in Dollar General Corporation as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 9 to Schedule 13G, reporting a 6.4% passive beneficial ownership stake in El Pollo Loco Holdings Inc. as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 12 to Schedule 13G, disclosing its beneficial ownership of 8.3% of Verint Systems Inc.'s common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 6.4% of Warby Parker Inc.'s Class A Stock as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 10 to its Schedule 13G, reporting a 7.8% beneficial ownership stake in Zimmer Biomet Holdings Inc. as of March 31, 2025, held for ordinary course of business purposes.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.7% beneficial ownership stake in AAON INC's common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 6.5% beneficial ownership stake in Accuray Inc.'s common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 8.4% of Alaska Air Group Inc.'s common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, confirming its beneficial ownership of 8.1% of Albemarle Corporation's common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 7.0% beneficial ownership stake in Align Technology Inc. as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.3% beneficial ownership stake in Allogene Therapeutics, Inc. as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 7.5% of American Electric Power Co Inc's common stock as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 11 to Schedule 13G, reporting a 6.9% beneficial ownership stake in American International Group Inc. as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.1% beneficial ownership stake in American Superconductor Corp as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 15 to its Schedule 13G, reporting a 7.6% beneficial ownership stake in Amgen Inc.'s common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.2% beneficial ownership stake in AnaptysBio Inc. as of March 31, 2025.